What if T cells return after CD7 CAR-T therapy—but antiviral immunity does not?
A new @BloodJournal study used MGI STOmics’ #StereoSeq and single-nucleus multi-omics to investigate EBV-positive lymphoproliferative disorder after CD7 CAR-T therapy. 🧵
A new @BloodJournal study used MGI STOmics’ #StereoSeq and single-nucleus multi-omics to investigate EBV-positive lymphoproliferative disorder after CD7 CAR-T therapy. 🧵